Switch to:
More From Other Websites
ResMed and Fairview Health Services Introduce Integration of Sleep and Respiratory Therapy Data into... Sep 15 2014
APEX and ResMed Resolve Patent Disputes Sep 04 2014
Resmed (RMD) Shares Up on Favorable Sleep Apnea Study Sep 04 2014
Stock Picks For An Emerging Markets Selloff Sep 02 2014
ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available... Sep 02 2014
ESC Congress 2014 Highlights: Heart Failure Patients with Sleep-Disordered Breathing More Accurately... Aug 31 2014
ESC Congress 2014 highlights: Treating cardiac patients who have sleep apnoea with positive airway... Aug 31 2014
ResMed Continues to Disappoint despite OSA Market Potential Aug 25 2014
ResMed Wins Initial Decision in ITC Patent Infringement Action Aug 24 2014
ResMed Introduces AirSense 10 Devices to Treat Sleep Apnea Aug 19 2014
ResMed's New AirSense 10 CPAP and APAP Devices Deliver Superior Patient Comfort and Cost-Saving... Aug 18 2014
RESMED INC Financials Aug 15 2014
ResMed (RMD) Launches Air Solutions for Improved SDB Therapy Aug 12 2014
Qualcomm announces new connected health collaborations at Connect 2014 Aug 12 2014
A New Beginning: ResMed's New Air Solutions Connected Care Platform for Treating Sleep-Disordered... Aug 11 2014
A New Beginning: ResMed's New Air Solutions Connected Care Platform for Treating Sleep-Disordered... Aug 11 2014
RESMED INC Files SEC form 10-K, Annual Report Aug 08 2014
The R&D elite: America's most innovative companies Aug 06 2014
ResMed Misses on Q4 Earnings and Revenues, Hikes Dividend Aug 04 2014
Long-term Non-invasive Positive Pressure Ventilation Treatment Delivers 76 Percent Reduction in Risk... Aug 04 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK